EDRS
AVDL

Edmond de Rothschild (Suisse)’s Avadel Pharmaceuticals AVDL Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$50K Hold
4,000
– – 0.02% 315
2016
Q2 		$43K Hold
4,000
– – 0.01% 301
2016
Q1 		$44K Hold
4,000
– – 0.02% 266
2015
Q4 		$49K Sell
4,000
-86,798
-96% -$1.35M 0.02% 246
2015
Q3 		$1.48M Buy
90,798
+45,398
+100% +$1,000K 0.5% 48
2015
Q2 		$962K Buy
+45,400
New +$814K 0.31% 70

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.94% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s AVDL Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) held its Avadel Pharmaceuticals (AVDL) position steady in Q3 2016 at 4,000 shares worth $50K. The position accounts for 0.02% of the portfolio, ranked #315.

Edmond de Rothschild (Suisse) first reported a position in AVDL in Q2 2015 and has held it in 6 quarters since. The position peaked at $1.48M in Q3 2015. 87 funds tracked by Wall St. Rank hold AVDL as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 4,000 shares of Avadel Pharmaceuticals worth $50K as of Q3 2016.
  • Edmond de Rothschild (Suisse) left its Avadel Pharmaceuticals share count unchanged in Q3 2016.
  • Avadel Pharmaceuticals made up 0.02% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #315 holding.
  • Edmond de Rothschild (Suisse) first reported a position in Avadel Pharmaceuticals in Q2 2015 and has held it in 6 quarters since.
  • Edmond de Rothschild (Suisse)'s Avadel Pharmaceuticals position peaked at $1.48M in Q3 2015.
  • 87 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.